Cargando…
Multiple Sites of Type II Site Ligand (Luteolin and BMHPC) Regulation of Gene Expression in PC-3 Cells
Type II [(3)H]estradiol binding site ligands including luteolin (a naturally occurring bioflavonoid) and synthetic compounds such as 2,6-bis((3-methoxy-4-hydroxyphenyl)methylene)cyclohexanone (BMHPC) inhibit normal and malignant prostate cell (PC-3, LNCaP, DU-145) proliferation in vitro and in vivo....
Autores principales: | Markaverich, Barry M., Vijjeswarapu, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615297/ https://www.ncbi.nlm.nih.gov/pubmed/23675277 |
Ejemplares similares
-
Luteolin Regulation of Estrogen Signaling and Cell Cycle Pathway Genes in MCF-7 Human Breast Cancer Cells
por: Markaverich, Barry M., et al.
Publicado: (2011) -
Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells
por: Lin, Lian-Fang, et al.
Publicado: (2012) -
Double-Site Binding and Anti-/Pro-oxidation of Luteolin
on Bovine Serum Albumin Mediated by Copper(II) Coordination
por: Song, Meng-Ting, et al.
Publicado: (2022) -
Recruitment of RNA polymerase II cofactor PC4 to DNA damage sites
por: Mortusewicz, Oliver, et al.
Publicado: (2008) -
Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells
por: Seo, Yohan, et al.
Publicado: (2017)